Related Experiment Video
Updated: Feb 28, 2026

09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
3.6K
Individuals' preferences for future biological sample and genomic data sharing in the Australian Reproductive Genetic
Matilda A Haas1,2, Evanthia O Madelli3,4, Martin B Delatycki4,5
1Australian Genomics, Parkville, VIC, Australia. matildahaas@gmail.com.
European Journal of Human Genetics : EJHG
|February 25, 2026
Summary
Most individuals in genomic research prefer specific consent for data sharing, with clear preferences for non-profit and university research. Flexible consent models are essential for managing genomic data responsibly.
Area of Science:
- Genomics
- Bioethics
- Population Health
Background:
- Genomic research data is valuable for secondary research.
- Participant comfort with broad consent for data sharing is largely unknown.
- Population reproductive carrier screening is feasible and acceptable.
Purpose of the Study:
- Investigate feasibility and acceptability of population reproductive carrier screening.
- Determine participant preferences for future genomic data sharing.
- Assess comfort levels with broad consent versus specific consent scenarios.
Main Methods:
- Digital enrollment and consent via online Portal or REDCap.
- Included optional questions on future research use preferences.
- Collected demographic data and consent preferences from participants.
Main Results:
- 23.5% provided specific consent preferences; 76.5% gave broad consent.
- Participants favored sharing with non-profits (78.0%) and universities (78.2%).
- Lower consent for government (59.2%) and commercial (33.7%) use; 60% want data sharing notifications.
Conclusions:
- Research programs need flexible, dynamic consent models.
- Participant-led choices reduce ambiguity in data sharing permissions.
- Scalable models for managing genomic data consent are demonstrated.
Related Concept Videos
Genetic Screens
5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K

